TipRanks
Advertisement
Advertisement
Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study
PremiumCompany AnnouncementsBluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study
3M ago
Bluejay Diagnostics completes enrollment in SYMON-II study
Premium
The Fly
Bluejay Diagnostics completes enrollment in SYMON-II study
3M ago
Bluejay Diagnostics Advances Symphony IL-6 Sepsis Pilot, Keeping Investor Focus on ER Diagnostics
Premium
Company Announcements
Bluejay Diagnostics Advances Symphony IL-6 Sepsis Pilot, Keeping Investor Focus on ER Diagnostics
3M ago
Bluejay Diagnostics Forms U.S. Manufacturing Partnership for Symphony
PremiumCompany AnnouncementsBluejay Diagnostics Forms U.S. Manufacturing Partnership for Symphony
4M ago
Bluejay Diagnostics, Argonaut Manufacturing Services announce partnership
Premium
The Fly
Bluejay Diagnostics, Argonaut Manufacturing Services announce partnership
4M ago
Bluejay Nears Completion of Pivotal SYMON-II Sepsis Trial
Premium
Company Announcements
Bluejay Nears Completion of Pivotal SYMON-II Sepsis Trial
6M ago
NorthStrive Fund urges Bluejay to evaluate strategic opportunity
PremiumThe FlyNorthStrive Fund urges Bluejay to evaluate strategic opportunity
7M ago
Bluejay Diagnostics says SYMON II study ‘progressing as planned’
Premium
The Fly
Bluejay Diagnostics says SYMON II study ‘progressing as planned’
7M ago
Bluejay Diagnostics Completes Warrant Exercises, Clarifies Capital Structure
Premium
Company Announcements
Bluejay Diagnostics Completes Warrant Exercises, Clarifies Capital Structure
8M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―